Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, David C. Airey, Nicholas K. Proctor, Xiyun Chai, Sergey Shcherbinin, John R. Sims, Jeffrey L. Dage, Oskar Hansson
medRxiv 2020.01.15.20017236; doi: https://doi.org/10.1101/2020.01.15.20017236